Post-earnings recap
Reported
Tue, Nov 7, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp's strong EPS performance, beating expectations by nearly 10%, led to a significant stock increase of almost 10%. The lack of revenue details may raise questions among investors, but the positive EPS surprise suggests effective cost management. The management's cautious optimism indicates they are focused on improving operations moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.48 | N/A | +9.66% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a sense of cautious optimism regarding the company's performance. They emphasized their focus on enhancing operational efficiencies.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing efforts to improve operational efficiencies.